Gossamer Bio (GOSS) Reports Q1 Loss, Tops Revenue Estimates

  • Gossamer Bio (GOSS) came out with a quarterly loss of $0.16 per share versus the Zacks Consensus Estimate of a loss of $0.18. This compares to loss of $0.19 per share a year ago.